Of the 14 semaglutide-treated patients that developed anti-semaglutide antibodies, 7 patients (0.2% of the overall population) developed antibodies cross-reacting with native GLP-1
-20C, 1 month (sealed storage, away from moisture)
Longevity protocol: Dose: 0.5-1mg daily (lower end) Frequency: 3-5 times weekly Cycle: 8 weeks on, 4 weeks off, indefinite repetition Combine with: Overall health optimization (sleep, nutrition, exercise) Lower doses for longevity reduce cost and theoretical concerns about long-term copper peptide use while potentially maintaining meaningful benefits
These guidelines incorporate factors such as the patients BMI, the presence of weight-related comorbidities, and individual risk factors
Even simple anaemia affects many organ systems: fatigue, pallor, abdominal complaints, high heart rate, shortness of breath when climbing stairs, and dizziness
Read more about Crohns disease